ANAB Overview
Upcoming Projects (ANAB)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ANAB)
-
A Third View: Diving into the GEMINI-2 Phase 3 clinical trial data on imsidolimab in patients with GPP.
Ticker: ANAB
Executed On: May 21, 2024 at 10:00 AM EDT -
A Second View: Diving into the GEMINI-2 Phase 3 clinical trial data on imsidolimab in patients with GPP.
Ticker: ANAB
Executed On: May 20, 2024 at 07:00 PM EDT -
Diving into the GEMINI-2 Phase 3 clinical trial data on imsidolimab in patients with GPP.
Ticker: ANAB
Executed On: May 16, 2024 at 11:00 AM EDT -
A Third View: Understanding the standard of care for generalized pustular psoriasis (GPP) and the potential of AnaptysBio's imsidolimab (IL-36R mAB)
Ticker: ANAB
Executed On: Oct 25, 2023 at 03:00 PM EDT -
A Second View: Understanding the standard of care for generalized pustular psoriasis (GPP) and the potential of AnaptysBio's imsidolimab (IL-36R mAB)
Ticker: ANAB
Executed On: Oct 19, 2023 at 10:00 AM EDT -
Understanding the standard of care for generalized pustular psoriasis (GPP) and the potential of AnaptysBio's imsidolimab (IL-36R mAB)
Ticker: ANAB
Executed On: Oct 19, 2023 at 08:30 AM EDT -
A Third Look at the approved Abbvie's Humira and the general landscape of HS treatments on the horizon
Tickers: ABBV, NVS, ANAB
Executed On: Aug 05, 2022 at 01:00 PM EDT -
A Second Look at the approved Abbvie's Humira and the general landscape of HS treatments on the horizon
Tickers: ABBV, NVS, ANAB
Executed On: Aug 05, 2022 at 08:30 AM EDT -
A look at imsidolimab for acne vulgaris
Ticker: ANAB
Executed On: Mar 08, 2022 at 11:00 AM EST
Upcoming & Overdue Catalysts (ANAB)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ANAB)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
